Navigation Links
Quark Pharmaceuticals Reports Favorable Interim Results from Phase I Clinical Study of QPI-1007 in Patients with Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Date:1/4/2012

iliary artery. Vision loss resulting from NAION is typically sudden and painless, and in most cases patients have permanent visual deficits. There are no approved therapies available for these patients.

About Quark Pharmaceuticals, Inc.

Quark Pharmaceuticals, Inc., is a clinical-stage pharmaceutical company engaged in discovering and developing novel RNAi-based therapeutics. The Company has a fully integrated drug development platform that spans therapeutic target identification based on its proprietary gene discovery technology, to clinical drug development. Quark has three product candidates in clinical development in five different disease indications of which four are in Phase 2. QPI-1007, a chemically modified synthetic siRNA, is Quark's first drug candidate based on novel siRNA structures developed though an internal program conducted by Quark in collaboration with BioSpring AG.

Quark is committed to leveraging a broad research pipeline of siRNA drug candidates and novel siRNA structures to develop additional RNAi drug candidates.

Quark is headquartered in Fremont, California and operates research and development facilities in Boulder, Colorado and Ness-Ziona, Israel. Additional information is available at www.quarkpharma.com.

(1) The Ischemic Optic Neuropathy Decompression Trial Research Group (1995). Optic Nerve Decompression Surgery for Nonarteritic Anteriror Ischemic Optic Neuropathy (NAION) is Not Effective and May Be Harmful. JAMA, Vol.273, pp.625 – 632; and (2) Hayreh S.S. & Zimmerman M.B. (2008). Non-arteritic Anterior Ischemic Optic Neuropathy. Natural History of Visual Outcome. J. Ophthalmology, pp.298-305.

 

'/>"/>

Quark Pharmaceuticals, Inc.

Juliana Friedman

+972 89 30 5111

jfriedman@quarkpharma.com

 

 


SOURCE Quark Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
3. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
4. Quark Pharmaceuticals Appoints New Chief Medical Officer
5. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
6. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
7. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
8. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
9. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
10. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
11. Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 2015   Turing Pharmaceuticals AG announced today ... company as its first Chief Communication Officer. ... responsibility for internal and external communications and will provide ... report directly to Founder and Chairman, Martin Shkreli ... "We are excited to have Craig join ...
(Date:7/29/2015)... 27, 2015 Research and Markets ( http://www.researchandmarkets.com/research/sxwk89/3d_metrology ... Metrology Market by Product (CMM, ODS, and VMM), Application ... Geography (North America, Europe, APAC, RoW) - Global Forecast ... The 3D metrology market was valued at ... at a rate of 7.11% during the forecast period. ...
(Date:7/29/2015)... July 29, 2015 At the 2015 ... will present findings that a first-of-its-kind smartphone test ... accuracy, which could reduce the prevalence of this ... easier and cheaper. Most people with ... infection often causes no symptoms, but if left ...
Breaking Medicine Technology:Turing Pharmaceuticals Names Craig Rothenberg Chief Communication Officer 2Turing Pharmaceuticals Names Craig Rothenberg Chief Communication Officer 3Global 3D Metrology Market 2015-2020: Products (CMM, ODS, and VMM) & Applications (Automotive, Aerospace, Energy & Power, Medical and Electronics) 2First Smartphone DNA Test for Chlamydia to Be Presented at 2015 AACC Annual Meeting 2First Smartphone DNA Test for Chlamydia to Be Presented at 2015 AACC Annual Meeting 3
... (Nasdaq: MYL ) today announced that its ... mg and 200 mg, under a previously announced settlement ... first company to have filed a substantially complete ANDA ... was awarded 180 days of marketing exclusivity.   ...
... Feb. 15, 2011 Lexicon Pharmaceuticals, Inc. ... on discovering and developing breakthrough treatments for human disease, ... financial results on Thursday, February 24, 2011 before the ... call and webcast to discuss clinical development progress and ...
Cached Medicine Technology:Lexicon to Report Fourth Quarter and Year End 2010 Financial Results on February 24, 2011 2
(Date:7/29/2015)... ... July 29, 2015 , ... Conventional theories used by economists for the past ... be able to unlock mysteries about the behavior of microbial life on earth, according ... Columbia University. , The findings, published July 29 in the open access journal PLOS ...
(Date:7/29/2015)... ... , ... Abt Associates has named Selena Ramkeesoon, a strategic ... her position, Ramkeesoon will help build and expand work in communications, and the ... a decade at ICF International, most recently as a vice president. During her ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... paper, Our Best Shot: Expanding Prevention through Vaccination in Older Adults, that provides ... offers recommendations on how industry, government, and health care experts can improve patient ...
(Date:7/29/2015)... ... July 29, 2015 , ... Angelo’s FabriClean, an area ... service: water damage restoration of carpets and rugs. The company will now reverse the ... commercial clients. , An overflowing overhead tank, rain leaking through an accidently left ...
(Date:7/29/2015)... , ... July 29, 2015 , ... Ticket Down is ... featuring Brazil vs. USA . , The international soccer schedule of ... grown exponentially and now on September 8th, one of the world’s greatest teams, Brazil, ...
Breaking Medicine News(10 mins):Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 3Health News:Selena Ramkeesoon Joins Abt Associates as Vice President for Strategic Communications 2Health News:Vaccination Rates in Older Adults Fall Short of Targets 2Health News:Vaccination Rates in Older Adults Fall Short of Targets 3Health News:Angelo’s FabriClean Now Offers Water Damage Restoration For Residential and Commercial Accounts 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 3
... quality of life (HRQOL) for U.S. adults with arthritis is ... and mental health are affected by arthritis, which poses a ... diagnosed continues to climb. Details of this study are now ... published by Wiley-Blackwell on behalf of the American College of ...
... E improved the most severe form of fatty liver disease ... National Institutes of Health. Results appear in the April 27 ... . A previous study found vitamin E effective in some ... (NAFLD) is the most common chronic liver disease among U.S. ...
... WEDNESDAY, April 27 (HealthDay News) -- Group visits to a ... The new study included 14 patients who received care through ... 13 patients who received usual care. The study participants had ... care group had 30-minute appointments with their doctor every three ...
... rough and tumble of post-graduation life, white blood cells trained ... when injected into cancer patients. Dana-Farber Cancer Institute scientists, however, ... survive in patients, bloodstreams for well over a year, in ... a new study shows. In a paper published in ...
... HealthDay Reporter , WEDNESDAY, April 27 (HealthDay News) -- About ... -- live in areas where the air is so polluted that ... Residents of Honolulu and Santa Fe-Espanola, N.M., on the other hand, ... the country,s cleanest -- and they were the only two in ...
... Reporter , TUESDAY, April 26 (HealthDay News) -- Every ... worries about the food her daughter might choose to eat. ... a small amount of a peanut-containing food could cause a ... now that she,s a teenager and is eating out with ...
Cached Medicine News:Health News:Adults with arthritis suffer with poorer health related quality of life 2Health News:Vitamin E helps diminish a type of fatty liver disease in children 2Health News:Vitamin E helps diminish a type of fatty liver disease in children 3Health News:Group Visits With Doctor May Benefit Parkinson's Patients 2Health News:New technique extends cancer-fighting cells' potency in melanoma patients 2Health News:New technique extends cancer-fighting cells' potency in melanoma patients 3Health News:New technique extends cancer-fighting cells' potency in melanoma patients 4Health News:Report: California Cities Have Worst Air Pollution in U.S. 2Health News:Report: California Cities Have Worst Air Pollution in U.S. 3Health News:Report: California Cities Have Worst Air Pollution in U.S. 4Health News:Anxiety's on the Menu for People With Food Allergies 2Health News:Anxiety's on the Menu for People With Food Allergies 3
Female High Waist Briefs...
Arm Compression Garment...
... Crafted from medium ... Bolero jacket provides upper ... support for the arms. ... adjusted without Wonderfabric™ unraveling. ...
This compression garment can be used for Breast Augmentation, Augmentation Mammaplasty, Trans Umbilical Breast Augmentation, Transaxillary Submuscular Augmentation....
Medicine Products: